first day of tirzepatide What to expect after your dose tirzepatide: the complete hour-by-hour guide Can you take tirzepatide a
Description
The phase 2b clinical trial of bofanglutide included 272 adults with type 2 diabetes, with an average age of 50.8, from 37 sites across China
Some studies suggest GLP-1 agonists may reduce serum uric acid through increased renal excretion and weight loss, though the effect is modest and not consistently replicated
All patients were of White Greek ethnic origin, mostly females (28/40 or 70%), with a median age of 47, ranging from 23 to 65 years old
GLP-1 receptor agonists cause nausea by delaying gastric emptying, with rates varying from 8% to 44% depending on the specific medication and dose
